Toll Free: 1-888-928-9744
Published: Jul, 2014 | Pages:
36 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
OncoTherapy Science, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'OncoTherapy Science, Inc. - Product Pipeline Review - 2014', provides an overview of the OncoTherapy Science, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of OncoTherapy Science, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of OncoTherapy Science, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of OncoTherapy Science, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the OncoTherapy Science, Inc.'s pipeline products Reasons to buy - Evaluate OncoTherapy Science, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of OncoTherapy Science, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the OncoTherapy Science, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of OncoTherapy Science, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of OncoTherapy Science, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of OncoTherapy Science, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 OncoTherapy Science, Inc. Snapshot 5 OncoTherapy Science, Inc. Overview 5 Key Information 5 Key Facts 5 OncoTherapy Science, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 OncoTherapy Science, Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Partnered Products 11 Partnered Products/Combination Treatment Modalities 12 Pipeline Products - Out-Licensed Products 13 Out-Licensed Products/Combination Treatment Modalities 14 OncoTherapy Science, Inc. - Pipeline Products Glance 15 OncoTherapy Science, Inc. - Clinical Stage Pipeline Products 15 Phase II Products/Combination Treatment Modalities 15 Phase I Products/Combination Treatment Modalities 16 OncoTherapy Science, Inc. - Early Stage Pipeline Products 17 Preclinical Products/Combination Treatment Modalities 17 OncoTherapy Science, Inc. - Drug Profiles 18 elpamotide 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 OCV-C01 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 OTSGC-A24 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 NCV-01 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 ONO-7268MX1 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 ONO-7268MX2 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 OTS-167 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 OTSA-101 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 OTS-964 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 OncoTherapy Science, Inc. - Pipeline Analysis 28 OncoTherapy Science, Inc. - Pipeline Products by Target 28 OncoTherapy Science, Inc. - Pipeline Products by Route of Administration 29 OncoTherapy Science, Inc. - Pipeline Products by Molecule Type 30 OncoTherapy Science, Inc. - Pipeline Products by Mechanism of Action 31 OncoTherapy Science, Inc. - Recent Pipeline Updates 32 OncoTherapy Science, Inc. - Dormant Projects 33 OncoTherapy Science, Inc. - Locations And Subsidiaries 34 Head Office 34 Other Locations & Subsidiaries 34 Appendix 35 Methodology 35 Coverage 35 Secondary Research 35 Primary Research 35 Expert Panel Validation 35 Contact Us 36 Disclaimer 36
List of Tables OncoTherapy Science, Inc., Key Information 5 OncoTherapy Science, Inc., Key Facts 5 OncoTherapy Science, Inc. - Pipeline by Indication, 2014 8 OncoTherapy Science, Inc. - Pipeline by Stage of Development, 2014 9 OncoTherapy Science, Inc. - Monotherapy Products in Pipeline, 2014 10 OncoTherapy Science, Inc. - Partnered Products in Pipeline, 2014 11 OncoTherapy Science, Inc. - Partnered Products/ Combination Treatment Modalities, 2014 12 OncoTherapy Science, Inc. - Out-Licensed Products in Pipeline, 2014 13 OncoTherapy Science, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2014 14 OncoTherapy Science, Inc. - Phase II, 2014 15 OncoTherapy Science, Inc. - Phase I, 2014 16 OncoTherapy Science, Inc. - Preclinical, 2014 17 OncoTherapy Science, Inc. - Pipeline by Target, 2014 28 OncoTherapy Science, Inc. - Pipeline by Route of Administration, 2014 29 OncoTherapy Science, Inc. - Pipeline by Molecule Type, 2014 30 OncoTherapy Science, Inc. - Pipeline Products by Mechanism of Action, 2014 31 OncoTherapy Science, Inc. - Recent Pipeline Updates, 2014 32 OncoTherapy Science, Inc. - Dormant Developmental Projects,2014 33 OncoTherapy Science, Inc., Subsidiaries 34
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.